Prevention and early detection of prostate cancer.
Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer. Early detection of prostate cancer by prostate-speci...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
Lancet
2014
|
| _version_ | 1826279187859636224 |
|---|---|
| author | Cuzick, J Thorat, M Andriole, G Brawley, O Brown, P Culig, Z Eeles, R Ford, L Hamdy, F Holmberg, L Ilic, D Key, T La Vecchia, C Lilja, H Marberger, M Meyskens, F Minasian, L Parker, C Parnes, H Perner, S Rittenhouse, H Schalken, J Schmid, H Schmitz-Dräger, B Schröder, F |
| author_facet | Cuzick, J Thorat, M Andriole, G Brawley, O Brown, P Culig, Z Eeles, R Ford, L Hamdy, F Holmberg, L Ilic, D Key, T La Vecchia, C Lilja, H Marberger, M Meyskens, F Minasian, L Parker, C Parnes, H Perner, S Rittenhouse, H Schalken, J Schmid, H Schmitz-Dräger, B Schröder, F |
| author_sort | Cuzick, J |
| collection | OXFORD |
| description | Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer. Early detection of prostate cancer by prostate-specific antigen (PSA) screening is controversial, but changes in the PSA threshold, frequency of screening, and the use of other biomarkers have the potential to minimise the overdiagnosis associated with PSA screening. Several new biomarkers for individuals with raised PSA concentrations or those diagnosed with prostate cancer are likely to identify individuals who can be spared aggressive treatment. Several pharmacological agents such as 5α-reductase inhibitors and aspirin could prevent development of prostate cancer. In this Review, we discuss the present evidence and research questions regarding prevention, early detection of prostate cancer, and management of men either at high risk of prostate cancer or diagnosed with low-grade prostate cancer. |
| first_indexed | 2024-03-06T23:55:02Z |
| format | Journal article |
| id | oxford-uuid:73e906bc-9b84-46e1-a56e-db0fa87ef6ce |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:55:02Z |
| publishDate | 2014 |
| publisher | Lancet |
| record_format | dspace |
| spelling | oxford-uuid:73e906bc-9b84-46e1-a56e-db0fa87ef6ce2022-03-26T19:59:31ZPrevention and early detection of prostate cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:73e906bc-9b84-46e1-a56e-db0fa87ef6ceEnglishSymplectic Elements at OxfordLancet2014Cuzick, JThorat, MAndriole, GBrawley, OBrown, PCulig, ZEeles, RFord, LHamdy, FHolmberg, LIlic, DKey, TLa Vecchia, CLilja, HMarberger, MMeyskens, FMinasian, LParker, CParnes, HPerner, SRittenhouse, HSchalken, JSchmid, HSchmitz-Dräger, BSchröder, FProstate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer. Early detection of prostate cancer by prostate-specific antigen (PSA) screening is controversial, but changes in the PSA threshold, frequency of screening, and the use of other biomarkers have the potential to minimise the overdiagnosis associated with PSA screening. Several new biomarkers for individuals with raised PSA concentrations or those diagnosed with prostate cancer are likely to identify individuals who can be spared aggressive treatment. Several pharmacological agents such as 5α-reductase inhibitors and aspirin could prevent development of prostate cancer. In this Review, we discuss the present evidence and research questions regarding prevention, early detection of prostate cancer, and management of men either at high risk of prostate cancer or diagnosed with low-grade prostate cancer. |
| spellingShingle | Cuzick, J Thorat, M Andriole, G Brawley, O Brown, P Culig, Z Eeles, R Ford, L Hamdy, F Holmberg, L Ilic, D Key, T La Vecchia, C Lilja, H Marberger, M Meyskens, F Minasian, L Parker, C Parnes, H Perner, S Rittenhouse, H Schalken, J Schmid, H Schmitz-Dräger, B Schröder, F Prevention and early detection of prostate cancer. |
| title | Prevention and early detection of prostate cancer. |
| title_full | Prevention and early detection of prostate cancer. |
| title_fullStr | Prevention and early detection of prostate cancer. |
| title_full_unstemmed | Prevention and early detection of prostate cancer. |
| title_short | Prevention and early detection of prostate cancer. |
| title_sort | prevention and early detection of prostate cancer |
| work_keys_str_mv | AT cuzickj preventionandearlydetectionofprostatecancer AT thoratm preventionandearlydetectionofprostatecancer AT andrioleg preventionandearlydetectionofprostatecancer AT brawleyo preventionandearlydetectionofprostatecancer AT brownp preventionandearlydetectionofprostatecancer AT culigz preventionandearlydetectionofprostatecancer AT eelesr preventionandearlydetectionofprostatecancer AT fordl preventionandearlydetectionofprostatecancer AT hamdyf preventionandearlydetectionofprostatecancer AT holmbergl preventionandearlydetectionofprostatecancer AT ilicd preventionandearlydetectionofprostatecancer AT keyt preventionandearlydetectionofprostatecancer AT lavecchiac preventionandearlydetectionofprostatecancer AT liljah preventionandearlydetectionofprostatecancer AT marbergerm preventionandearlydetectionofprostatecancer AT meyskensf preventionandearlydetectionofprostatecancer AT minasianl preventionandearlydetectionofprostatecancer AT parkerc preventionandearlydetectionofprostatecancer AT parnesh preventionandearlydetectionofprostatecancer AT perners preventionandearlydetectionofprostatecancer AT rittenhouseh preventionandearlydetectionofprostatecancer AT schalkenj preventionandearlydetectionofprostatecancer AT schmidh preventionandearlydetectionofprostatecancer AT schmitzdragerb preventionandearlydetectionofprostatecancer AT schroderf preventionandearlydetectionofprostatecancer |